SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

In a phase 2 trial, outpatients with Covid-19 who received a single infusion of a 2800-mg dose of the neutralizing antibody LY-CoV555 had a greater reduction from baseline in viral load than those who received placebo. Hospitalization was less frequent among antibody-treated patients (1.6% vs. 6.3%)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine Jg. 384; H. 3; S. 229 - 237
Hauptverfasser:	Chen, Peter, Nirula, Ajay, Heller, Barry, Gottlieb, Robert L, Boscia, Joseph, Morris, Jason, Huhn, Gregory, Cardona, Jose, Mocherla, Bharat, Stosor, Valentina, Shawa, Imad, Adams, Andrew C, Van Naarden, Jacob, Custer, Kenneth L, Shen, Lei, Durante, Michael, Oakley, Gerard, Schade, Andrew E, Sabo, Janelle, Patel, Dipak R, Klekotka, Paul, Skovronsky, Daniel M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Massachusetts Medical Society 21.01.2021
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antibodies Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Neutralizing - administration & dosage Antibodies, Neutralizing - adverse effects Asymptomatic Clinical outcomes Coronaviridae Coronaviruses COVID-19 COVID-19 - drug therapy COVID-19 - virology Disease Dose-Response Relationship, Drug Double-Blind Method Emergency medical care Female Hospitalization - statistics & numerical data Humans Immunologic Factors - administration & dosage Immunologic Factors - adverse effects International organizations Intravenous administration Male Medical research Middle Aged Monoclonal antibodies Original Outpatients Pandemics Patients Placebos Reverse Transcriptase Polymerase Chain Reaction Ribonucleic acid Risk factors RNA RNA, Viral - blood SARS-CoV-2 - genetics SARS-CoV-2 - isolation & purification Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Statistical analysis Viral Load - drug effects Young Adult
ISSN:	0028-4793, 1533-4406, 1533-4406
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!